Rapid detection of mutations in CSF-cfTNA with the Genexus Integrated Sequencer
ConclusionIn summary, our results indicate that CSF-cfTNA analysis with the Genexus-OPA can provide clinically relevant information in patients with brain metastases with short TAT.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Lung Cancer | Neurology | Study